Studies to Investigate Adolescent HPV Vaccine Uptake

Nat'l Institutes of Health logoAgency: National Institutes of Health (HHS); Program: Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01) (CFDA Number: 93.393) (Funding Opportunity Number: PAR-16-338); Eligibility: Schools, governments, public and private colleges and universities, public housing authorities, nonprofits and for-profits; Funding: Multiple awards up to $200,000 each; Deadline: Oct. 5.

Summary: The program supports research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider’s recommendation of the adolescent human papillomavirus (HPV) vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.

Info: Questions, 301/435-0714; e-mail,; for the solicitation.

About Frank Klimko

Frank Klimko is a nationally known journalist, grants expert and speech writer/speaker. He has years of experience helping nonprofits devise lists of the right funding opportunities and secure funding from these foundations and corporate entities. Clients have focused on an array of areas including child care, homeless, hunger and K-12 education.

Additionally, he is a Freedom of Information Act expert, who has helped numerous clients with securing proprietary information from the federal government.

Currently, Frank Klimko writes the Children & Youth Funding Report and Private Grants Alert, which are Washington DC-based publications. CYF is a daily publication covering Congress, the Education Dept. and the various federal regulatory agencies. PGA, another daily publication, covers the world of private philanthropy.

This entry was posted in Federal Funding and tagged . Bookmark the permalink.